Invesco’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $469K | Sell |
122,566
-378,571
| -76% | -$1.45M | ﹤0.01% | 3183 |
|
|
2025
Q1 | $2.88M | Buy |
501,137
+471,231
| +1,576% | +$2.71M | ﹤0.01% | 2397 |
|
|
2024
Q4 | $149K | Sell |
29,906
-626,604
| -95% | -$3.13M | ﹤0.01% | 3550 |
|
|
2024
Q3 | $3.54M | Buy |
656,510
+626,646
| +2,098% | +$3.38M | ﹤0.01% | 2395 |
|
|
2024
Q2 | $98.9K | Sell |
29,864
-1,962
| -6% | -$6.49K | ﹤0.01% | 3740 |
|
|
2024
Q1 | $104K | Buy |
31,826
+61
| +0.2% | +$199 | ﹤0.01% | 3720 |
|
|
2023
Q4 | $111K | Sell |
31,765
-16,313
| -34% | -$57.3K | ﹤0.01% | 3661 |
|
|
2023
Q3 | $321K | Sell |
48,078
-467,263
| -91% | -$3.12M | ﹤0.01% | 3410 |
|
|
2023
Q2 | $4.32M | Buy |
515,341
+232,635
| +82% | +$1.95M | ﹤0.01% | 2313 |
|
|
2023
Q1 | $2.81M | Buy |
282,706
+35,655
| +14% | +$354K | ﹤0.01% | 2492 |
|
|
2022
Q4 | $1.72M | Buy |
247,051
+19,215
| +8% | +$134K | ﹤0.01% | 2694 |
|
|
2022
Q3 | $1.22M | Buy |
+227,836
| New | +$1.22M | ﹤0.01% | 2839 |
|
|
2022
Q2 | – | Sell |
-16,375
| Closed | -$73K | – | 4003 |
|
|
2022
Q1 | $73K | Sell |
16,375
-378
| -2% | -$1.69K | ﹤0.01% | 3857 |
|
|
2021
Q4 | $67K | Sell |
16,753
-6,605
| -28% | -$26.4K | ﹤0.01% | 3911 |
|
|
2021
Q3 | $205K | Buy |
23,358
+5,807
| +33% | +$51K | ﹤0.01% | 3758 |
|
|
2021
Q2 | $199K | Buy |
+17,551
| New | +$199K | ﹤0.01% | 3762 |
|
|
2020
Q4 | – | Sell |
-624,738
| Closed | -$4.63M | – | 3725 |
|
|
2020
Q3 | $4.63M | Buy |
+624,738
| New | +$4.63M | ﹤0.01% | 2043 |
|